-
Mashup Score: 27Circulating tumor DNA dynamic variation predicts sotorasib efficacy in KRASp.G12C‐mutated advanced non‐small cell lung cancer - 7 day(s) ago
Early clearance of circulating tumor DNA in patients who had advanced non-small cell cancer with a KRASp.G12C mutation predicted benefit from sotorasib therapy. Conversely, a dynamic increase in the …
Categories: General Medicine NewsTweet
-
Mashup Score: 18
This analysis of the use of palliative treatment among disaggregated Hispanic patients within the United States presents dual findings: the proportion of patients who received palliative-intent inter…
Categories: General Medicine NewsTweet-
‼️ New findings demonstrate disparities in the receipt of palliative-intent interventions among disaggregated Hispanic subgroups. Disaggregated research to further characterize these disparities and their drivers is needed. https://t.co/c4wwWqk4vw @oncoalert @EChrisDee #PallOnc https://t.co/GtUoKu2wyc
-
-
Mashup Score: 18CancerSpeak: A podcast from CANCER, a journal of the American Cancer Society | a podcast by ACS Journal Cancer - 7 day(s) ago
CancerSpeak is a podcast from CANCER, an interdisciplinary international journal of the American Cancer Society. Since 1948, CANCER has published high-impact, peer-reviewed original articles and solicited content on the latest clinical research findings. E…
Source: cancerspeak.podbean.comCategories: General Medicine News, Onc News and JournalsTweet-
📣 We are thrilled to announce the launch of our official podcast, CancerSpeak! 📗🎙️ Listen to the first 4 episodes of CancerSpeak featuring a conversation between @NNRTnews members on #PatientNavigation and cancer care 👇 https://t.co/wNmDRb0RlK https://t.co/CD0ogBbUNU
-
-
Mashup Score: 13Survival outcomes of pulmonary metastasis‐directed local therapy in adenoid cystic carcinoma - 8 day(s) ago
The largest study of survival outcomes of pulmonary metastasis–directed local therapy (PM-LT) in adenoid cystic carcinoma (ACC) and the only study to compare survival outcomes between patients who di…
Categories: General Medicine NewsTweet-
This is the largest study of survival outcomes of pulmonary metastasis–directed local therapy (PM-LT) in metastatic adenoid cystic carcinoma (ACC). Findings suggest PM-LT does not increase overall survival in unselected ACC. https://t.co/FWK368z4FX @OncoAlert https://t.co/YbEP17LZoL
-
-
Mashup Score: 7The American Cancer Society launches the VOICES of Black Women, a longitudinal population cohort study - 8 day(s) ago
The American Cancer Society has launched a new population cohort study, VOICES of Black Women, to examine the impact of established health determinants (e.g., smoking, exercise) and novel areas of em…
Categories: General Medicine NewsTweet-
.@AmericanCancer launched VOICES of Black Women in 2024 to address cancer disparities & improve outcomes among Black women. This editorial explores the study's rationale & early insights: https://t.co/iqjPObHobs @Dr_LEMcCullough @DrRobWinn @LRTeras @AlpaVPatel @OncoAlert https://t.co/lakxGd94hT
-
-
Mashup Score: 15
The combination of platinum/etoposide and nivolumab improves both progression-free survival and overall survival for patients with ES-SCLC. No new safety signals were observed.
Categories: General Medicine NewsTweet-
Just published: The combination of etoposide and nivolumab improves both progression-free survival and overall survival for patients with extensive-stage small cell lung cancer. https://t.co/yKvFuBtXYO @OncoAlert @LealTiciana @RamalingamMD @SclcSMASHERS #LCSM #SCLC https://t.co/rPaNC4tbhU
-
-
Mashup Score: 14A phase 1 dual‐dose escalation study of radiation and nab‐paclitaxel in patients with unresectable and borderline resectable pancreatic cancer - 10 day(s) ago
This phase 1 study shows the feasibility and safety of combining dose-escalated radiation (up to 60 Gy) with high-dose nab-paclitaxel for locally advanced pancreatic cancer, achieving low dose-limiti…
Categories: General Medicine NewsTweet-
This study demonstrates the feasibility and safety of combining dose-escalated radiation with high-dose nab-paclitaxel in locally advanced pancreatic cancer. https://t.co/xY0Vs57KDE @OncoAlert @PennMedicine #RadOnc https://t.co/2EEe5UytSB
-
-
Mashup Score: 6
Over a 20-year period, 4.5% (140 of 3125) of Canadian children who died of cancer were enrolled in early phase studies in their last 90 days of life. Enrollment was associated with a brain tumor diag…
Categories: General Medicine NewsTweet-
A small proportion of Canadian children and adolescents participate in early phase trials toward end of life. Future research should seek to address barriers to ensure equitable access for diverse populations. https://t.co/nHE0GbEViL @oncoalert @SickKidsGlobal @sung_lillian https://t.co/LYxOt7UDbU
-
-
Mashup Score: 11
In this episode of CancerSpeak, host Tyler Kratzer MPH is joined by coauthors Jessica Star MA, MPH; Scout MA, PhD; and Monique Gary DO to discuss the groundbreaking findings from the American Cancer Society’s latest report, “Cancer in People who Identify as Lesbian, Gay, Bisexual, Transgender, Queer, or Gender-nonconforming.” This landmark study is the first to provide a comprehensive national analysis of cancer risk factors and screening within LGBTQ+ populations. Listen in as the investigators delve into the unique challenges and disparities faced by LGBTQ+ communities and explore critical steps needed to improve cancer prevention and care. For the full text of the featured article, visit: https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.35355 Learn more about Welcoming Spaces: https://cancer-network.org/welcoming-spaces/ Music by Ivymusic from Pixabay
Source: cancerspeak.podbean.comCategories: General Medicine NewsTweet-
🎙️ 📗 A new episode of CancerSpeak is now available! This episode delves into the recent 1st-of-its-kind report from @AmericanCancer on the prevalence of cancer risks and screening among LGBTQ+ populations. Listen here: https://t.co/N7fyFU83w4 @oncoalert @ACSNews #PrideMonth https://t.co/nOFch4N9Il
-
-
Mashup Score: 6
A phase 2 trial demonstrated safety, feasibility, and efficacy of a single 25-mg dose of psilocybin combined with psychological support in a community cancer setting in patients with cancer and a maj…
Categories: General Medicine NewsTweet-
Can a psychedelic compound from mushrooms benefit people with cancer and major depression? 🍄 Results from a phase 2 study reveals that a single dose of psilocybin offers long-term relief from symptoms of depression and anxiety: https://t.co/Ifm55G9Q72 @OncoAlert @SunstoneHeals https://t.co/uhQhkPhoaC
-
New #OpenAccess research from @UmbertoMalapel1 et al in time for the conclusion of #ASCO25 | Circulating tumor DNA dynamic variation predicts sotorasib efficacy in KRASp.G12C-mutated advanced non-small cell lung cancer https://t.co/7D8Mw6RpF8 @OncoAlert #LCSM https://t.co/Gs9MNv4HoM